Cargando…
Final Results of the Telaprevir Access Program: FibroScan Values Predict Safety and Efficacy in Hepatitis C Patients with Advanced Fibrosis or Cirrhosis
BACKGROUND: Liver stiffness determined by transient elastography is correlated with hepatic fibrosis stage and has high accuracy for detecting severe fibrosis and cirrhosis in chronic hepatitis C patients. We evaluated the clinical value of baseline FibroScan values for the prediction of safety and...
Autores principales: | Lepida, Antonia, Colombo, Massimo, Fernandez, Inmaculada, Abdurakhmanov, Djamal, Abrao Ferreira, Paulo, Strasser, Simone I., Urbanek, Petr, Mangia, Alessandra, Calleja, José L., Iraqi, Wafae, DeMasi, Ralph, Lonjon-Domanec, Isabelle, Moreno, Christophe, Wedemeyer, Heiner |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4580464/ https://www.ncbi.nlm.nih.gov/pubmed/26398503 http://dx.doi.org/10.1371/journal.pone.0138503 |
Ejemplares similares
-
Safety and on-treatment efficacy of telaprevir: the early access programme for patients with advanced hepatitis C
por: Colombo, M, et al.
Publicado: (2014) -
Diagnostic Accuracy of FibroScan and Factors Affecting Measurements
por: Oeda, Satoshi, et al.
Publicado: (2020) -
Comparison of ELF, FibroTest and FibroScan for the non-invasive assessment of liver fibrosis
por: Friedrich-Rust, Mireen, et al.
Publicado: (2010) -
Enhanced diagnosis of advanced fibrosis and cirrhosis in individuals with NAFLD using FibroScan-based Agile scores
por: Sanyal, Arun J., et al.
Publicado: (2023) -
Treatment of hepatitis C genotype 1 patients with severe fibrosis or compensated cirrhosis: the telaprevir early access program in patients from Romania
por: Streinu-Cercel, Adrian, et al.
Publicado: (2013)